News Search

Category: School of Medicine

4D Molecular Therapeutics (4DMT) Acquires Rights to Penn Medicine Invented Technology from Aevitas Therapeutics

Penn spinout Aevitas Therapeutics recently executed an asset purchase agreement with California-based biotechnology company 4D Molecular Therapeutics (4DMT).

Adult Schizophrenia drug wins FDA approval

Teva Pharmaceuticals and MedinCell recently received approval from the U.S. Food and Drug Administration (FDA) for UZEDY™ (risperidone).

Penn Medicine Magazine Showcases Penn’s Drug Research and Development and Commercial Partnerships

The Spring 2023 issue of Penn Medicine Magazine describes how Penn has become a hub for drug research and development and created the infrastructure in both supporting clinical research and forging co

Bruce Levine Speaks on the Future of CAR-T Therapies

Levine explained that there are currently six approved CAR-T therapies and he estimates that between 25,000 and 30,000 patients have been treated with those therapies globally.


This technology is an intracerebral drug delivery system that consists of three flexible, retractable microcannulas housed within a single central catheter.

Penn Medicine, CHOP receive $25M anonymous gift to accelerate research in rare genetic brain disorders

The donation will establish the Center for Epilepsy and Neurodevelopmental Disorders, which will initially focus on developing therapies for disorders related to genetic mutations that are linked to a

Penn Scientists New Research Shows That a CAR-T gel Treatment May Be Able to Kill Residual Cancer Cells Left Over from Surgery

In the study, Penn scientists added CAR-T cells to a gel designed to prevent bleeding after surgery and applied it to the surgical wounds of mice after they had hard-to-treat tumors resected.

PCI Highlights mRNA Innovation at JPM

On January 9th, 2023 PCI was proud to present a star-studded program entitled “The Future of mRNA Technology” at Wharton San Francisco during the JP Morgan Healthcare Conference.

Katalin Karikó and Drew Weissman named to the National Inventors Hall of Fame

Karikó and Weissman were named to the National Inventors Hall of Fame for their mRNA research which made covid-19 vaccines possible.


Skip to content